Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.84 USD | -0.79% | +4.03% | +7.36% |
06/05 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
02/05 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.36% | 1.32TCr | |
+33.37% | 4.95TCr | |
+1.55% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.57% | 2.66TCr | |
-21.00% | 1.86TCr | |
+28.30% | 1.25TCr | |
+23.80% | 1.21TCr | |
-4.93% | 1.2TCr |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- RBC Lifts Price Target on Bio-Techne to $90 From $89 on View for Better 2024 EBITDA Margins, Keeps Sector Perform Rating